Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01961518 · ClinicalTrials.gov registry record
Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy Syndrome
A clinical trial of MPS IVA and MPS VI, sponsored by Greenwood Genetic Center.
- Completed
- Registry status
- 17
- Enrollment target
- 1
- Study location
NCT01961518: Completed study of MPS IVA and MPS VI, sponsored by Greenwood Genetic Center.
NCT01961518 is a study of MPS IVA and MPS VI that has completed, run by Greenwood Genetic Center. The registered enrollment target is 17 participants, below the 65-participant average among 5 other MPS IVA trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01961518, a study of MPS IVA and MPS VI, has completed, sponsored by Greenwood Genetic Center.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to identify patients with Morquio syndrome type A (MPS IVA) and Maroteaux-Lamy syndrome (MPS VI) who may have been missed or misdiagnosed due to atypical clinical features, a milder course, and/or negative urine screening. We will recruit participants who have certain hip and/or joint problems that could potentially be caused by one of these two genetic conditions through a chart review process conducted at Shriners Hospital for Children in Greenville, SC. Diagnostic testing will be performed for each participant to determine if he or she is affected by one of these two conditions. Results will be disclosed to all participants and their legal guardians, and appropriate follow up will be recommended for those who are found to have abnormal results.
Primary Outcome
The primary objective of this study is to identify patients with Morquio syndrome type A or Maroteaux-Lamy syndrome who may have been missed or misdiagnosed due to atypical clinical features, a milder course, and/or negative mucopolysaccharidosis urine screening.
Conditions Studied
Study Locations (1)
South Carolina
- Greenwood Genetic Center - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-05 |
What the finished NCT01961518 record still lists
NCT01961518 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 65-participant average among 5 other MPS IVA trials with a reported enrollment target (74% lower).
The record links to 4 conditions, with MPS IVA appearing as the primary indexed condition, and to 0 interventions.
NCT01961518 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT01961518 about?
NCT01961518 is a clinical study titled "Screening an Orthopedic Population for Mildly-affected Individuals With Morquio Syndrome A and Maroteaux-Lamy Syndrome". The purpose of this study is to identify patients with Morquio syndrome type A (MPS IVA) and Maroteaux-Lamy syndrome (MPS VI) who may have been missed or misdiagnosed due to atypical clinical features, a milder course, and/or negative urine screening. We will recruit participants who have certain hi...
What is the current status of trial NCT01961518?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2013-10. Estimated completion is 2015-05.
What conditions does trial NCT01961518 study?
This clinical trial studies the following conditions: MPS IVA, MPS VI, Maroteaux Lamy Syndrome, Morquio Syndrome A.
Who is sponsoring clinical trial NCT01961518?
This trial is sponsored by Greenwood Genetic Center, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01961518 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for MPS IVA
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Non-invasive Functional Assessment and Pathogenesis of Morquio A
RECRUITING
-
Cardiac Structure and Function in MPS
RECRUITING
-
PEARL (PrEnAtal Enzyme Replacement Therapy for Lysosomal Storage Disorders)
RECRUITING · Phase 1
-
Safety and Efficacy of Voxzogo for Growth Deficits in MPS IVA and VI
ACTIVE NOT RECRUITING · Phase 1
-
Gait Analysis in MPS IVA
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia